Healthcare Finance News July 1, 2021
Widespread use requires greater reimbursement and an enterprise-wide strategy.
Genomic data is giving insights into just what will work for a particular patient. This precision medicine is being used in pharmacogenomics, oncology, and immunotherapy.
But widespread use requires reimbursement and getting to a scale in which genomic data is integrated across the health system and the patient’s care journey.
On Tuesday, August 10, at 11 a.m. in the Venetian Murano 3204, Dr. Phillip Empey and Dr. Robert Bart will describe at the HIMSS21 annual conference how they’re using genomic data in personalized oncology treatments and pharmacogenomics in “Genomic Data in Health Systems: The Importance of an Enterprise-Wide Strategy.”
They’ll also discuss the results of survey data from A Centers for...
Today's Sponsors
Today's Sponsor